Join
Live feed
·
INSIDERFilingvia Quantisnow
Lantern Pharma Inc. logo

Director Keyser D Jeffrey bought $100,001 worth of shares (48,544 units at $2.06), increasing direct ownership by 106% to 94,303 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LTRN· Lantern Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LTRN (Lantern Pharma Inc.) and more on Quantisnow.